Home / Market News / $OPK

$OPK news and market catalysts

The 8 most recent market catalysts affecting $OPK, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

8 catalysts 2 high impact 7 bullish 0 bearish Healthcare
Nov 4, 2026 Corporate Catalyst Bullish Impact 92
OPKO Health Reports Third Quarter 2026 Financial Results and Provides Q4 Guidance
OPKO Health's Q3 2026 revenue of $65.4 million dramatically missed the FactSet consensus of $136.6 million, representing a substantial underperformance. This significant revenue sh…
Oct 16, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Reiterates Overweight on OPKO Health, Raises Price Target to $4
Piper Sandler analyst Edward Tenthoff reiterated an 'Overweight' rating on OPKO Health and raised the price target from $3 to $4. This analyst action signals a positive sentiment t…
Oct 15, 2026 Corporate Catalyst Bullish Impact 85
OPKO Health shares are trading higher after Labcorp agreed to acquire select assets of OPKO's subsidiary BioReference Health for $722 million in cash plus a potential $150 million earnout.
This is a significant corporate catalyst for OPKO Health (OPK) as the sale of BioReference Health assets for $722 million in cash, plus a potential $150 million earnout, provides a…
Aug 13, 2026 Corporate Catalyst Neutral Impact 65
OPKO Health Issues Additional $125M Of Senior Secured Notes To KKR's HealthCare Royalty For Non-Dilutive Funding
OPKO Health has successfully raised an additional $125 million through a non-dilutive financing arrangement with KKR's HealthCare Royalty. This deal leverages OPKO's future royalty…
Jul 28, 2026 Corporate Catalyst Bullish Impact 65
12 Health Care Stocks Moving In Tuesday's Intraday Session
The filing details the intraday performance of 12 healthcare stocks, with six experiencing significant gains and six experiencing substantial losses. The primary catalyst for sever…
Jul 28, 2026 Corporate Catalyst Bullish Impact 75
Opko Health shares are trading higher after the company reported better-than-expected Q2 sales results.
This headline represents a significant corporate catalyst for Opko Health. Better-than-expected sales directly impact a company's revenue and profitability outlook, often leading t…
Jul 27, 2026 Corporate Catalyst Bullish Impact 75
OPKO Health Raises FY2026 Sales Guidance from $530.000M-$560.000M to $560.000M-$585.000M vs $534.899M Est
OPKO Health (OPK) has announced a significant upward revision to its fiscal year 2026 sales guidance. The new range of $560 million-$585 million is substantially higher than both t…
Jul 27, 2026 Corporate Catalyst Bullish Impact 75
Opko Health shares are trading higher after the company reported better-tan-expected Q2 sales results.
This headline represents a significant corporate catalyst for Opko Health. Better-than-expected sales directly impact revenue and profitability projections, often leading to upward…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.